Skip Navigation


JAC Advance Access originally published online on September 27, 2005
Journal of Antimicrobial Chemotherapy 2005 56(5):887-892; doi:10.1093/jac/dki343
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/5/887    most recent
dki343v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lewis, R. E.
Right arrow Articles by Kontoyiannis, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, R. E.
Right arrow Articles by Kontoyiannis, D. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro

Russell E. Lewis1,2 and Dimitrios P. Kontoyiannis1,2,*

1 University of Houston College of Pharmacy, Houston, TX, USA; 2 Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA

Received 28 April 2005; returned 1 June 2005; revised 11 August 2005; accepted 30 August 2005

* Corresponding author. Tel: +1-713-792-6237; Fax: +1-713-745-6839; E-mail: dkontoyi{at}mdanderson.org

Objectives: Preclinical and clinical evidence indicate that echinocandin–triazole combinations provide enhanced killing versus triazoles alone against some Aspergillus isolates, however, in vitro test results designed to detect this combined effect are difficult to interpret.

Methods: We used a straightforward pharmacodynamic approach based on a microdilution format and a colorimetric analysis to harmonize growth end points.

Results: We detected a fourfold decrease in the EC90 of voriconazole when tested in combination with micafungin (4 mg/L) against isolates of Aspergillus fumigatus and Aspergillus terreus, but not against an isolate of Aspergillus flavus. Echinocandin-enhanced voriconazole activity was confirmed in A. fumigatus and A. terreus but not A. flavus by fluorescent morbidity staining and fluorescence microscopic analysis of damaged hyphae.

Conclusions: A microdilution-based pharmacodynamic method for testing antifungal combinations provides a less ambiguous description of the combined effects of antifungals against moulds and could be useful in reference laboratories that routinely evaluate the activity of antifungal combinations in vitro and in vivo.

Keywords: aspergillosis , echinocandins , triazoles


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Med MicrobiolHome page
Q. Guo, S. Sun, J. Yu, Y. Li, and L. Cao
Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods
J. Med. Microbiol., April 1, 2008; 57(4): 457 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Antachopoulos, J. Meletiadis, T. Sein, E. Roilides, and T. J. Walsh
Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia
Antimicrob. Agents Chemother., January 1, 2008; 52(1): 321 - 328.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.